ArticleMolecular oncology2020

CCL5 mediates target-kinase independent resistance to FLT3 inhibitors in FLT3-ITD-positive AML.

Silvia Waldeck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.